Physician profile
Laura Ramirez
NPI 1033345459
$2,124.49
in general payments reported to CMS, 2019-2025
17 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $269 · 2022: $376 · 2023: $341 · 2024: $754 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,479.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $814.60 | 2021-2025 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $268.07 | 2021-2023 | Leqvio |
| Lilly USA, LLC | $208.27 | 2023-2025 | Jardiance, Emgality, Mounjaro |
| Phathom Pharmaceuticals, INC. | $177.20 | 2024 | Voquezna |
| Glaxosmithkline, LLC. | $119.41 | 2024 | Arexvy |
| Amarin Pharma, INC. | $103.98 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.96 | 2023-2024 | |
| Corium, LLC | $53.00 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.84 | 2022-2024 | Cycloset, Xifaxan |
| Pfizer INC. | $48.86 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $44.49 | 2024 | Acthar |
| Shield Therapeutics INC | $39.79 | 2023 | Accrufer |
| Ucb, INC. | $39.66 | 2025 | Bimzelx |
| Optinose US, INC. | $30.90 | 2024 | |
| Verona Pharma, INC. | $28.07 | 2025 | Ohtuvayre |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $21.71 | 2023 | Cologuard Collection Kit |
| Cranial Technologies, INC | $14.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.